Astellas Gives Maruishi Sales And Manufacturing Rights For Tranquilizer Horizon
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharmaceuticals and Maruishi Pharmaceuticals announced July 10 the manufacture and sale of mild tranquilizer Horizon (diazepam) and analgesic Sosegon (pentazocine) have been approved, and that Maruishi will commence sales and information operations for the drugs Oct. 1.